We are live on ! Find out more
BSX icon

Boston Scientific

800 hedge funds and large institutions have $41.6B invested in Boston Scientific in 2020 Q1 according to their latest regulatory filings, with 89 funds opening new positions, 295 increasing their positions, 306 reducing their positions, and 132 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.89% less ownership

Funds ownership: 91.99%91.11% (-0.89%)

4% less repeat investments, than reductions

Existing positions increased: 295 | Existing positions reduced: 306

6% less funds holding

Funds holding: 853800 (-53)

16% less call options, than puts

Call options by funds: $173M | Put options by funds: $206M

21% less funds holding in top 10

Funds holding in top 10: 2923 (-6)

28% less capital invested

Capital invested by funds: $58B → $41.6B (-$16.4B)

33% less first-time investments, than exits

New positions opened: 89 | Existing positions closed: 132

Holders
800
Holders Change
-53
Holders Change %
-6.21%
% of All Funds
17.63%
Holding in Top 10
23
Holding in Top 10 Change
-6
Holding in Top 10 Change %
-20.69%
% of All Funds
0.51%
New
89
Increased
295
Reduced
306
Closed
132
Calls
$173M
Puts
$206M
Net Calls
-$33.3M
Net Calls Change
-$44.7M
Name Holding Trade Value Shares
Change
Change in
Stake
AB
226
Amalgamated Bank
New York
$7.57M -$297K -7,610 -3%
GCM
227
Grisanti Capital Management
New York
$7.33M +$1.07M +27,360 +14%
A
228
AustralianSuper
Australia
$7.24M -$157M -4,017,208 -95%
BPC
229
Banque Pictet & Cie
Switzerland
$7.22M +$2.8M +71,661 +48%
Group One Trading
230
Group One Trading
Illinois
$7.16M +$8.57M +219,415 New
NGM
231
North Growth Management
British Columbia, Canada
$7.08M -$1.02M -26,000 -11%
ProShare Advisors
232
ProShare Advisors
Maryland
$7.03M -$1.76M -45,131 -17%
GF
233
Gabelli Funds
New York
$7.01M
MSL
234
Mackay Shields LLC
New York
$6.97M -$57.5K -1,471 -0.7%
Capital International Investors
235
Capital International Investors
California
$6.77M +$257K +6,590 +3%
AAM
236
Advisors Asset Management
Colorado
$6.6M -$119K -3,046 -1%
MSA
237
Mason Street Advisors
Wisconsin
$6.49M
BII
238
Bainco International Investors
Massachusetts
$6.38M +$15.5K +397 +0.2%
MOACM
239
Mutual of America Capital Management
New York
$6.34M +$68.3K +1,748 +0.9%
WC
240
Wexford Capital
Florida
$6.14M -$5.59M -143,127 -43%
SC
241
SouthState Corp
Florida
$6.09M +$423K +10,825 +6%
AIMCA
242
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$5.91M
FP
243
Financial Perspectives
Minnesota
$5.91M +$147K +3,760 +2%
Jane Street
244
Jane Street
New York
$5.85M +$7.01M +179,396 New
CIBC World Market
245
CIBC World Market
Ontario, Canada
$5.85M -$1.28M -32,811 -15%
SCI
246
S&CO Inc
Massachusetts
$5.81M -$7.03K -180 -0.1%
PL
247
Perpetual Ltd
Australia
$5.81M +$6.96M +178,038 New
TU
248
TDAM USA
Ontario, Canada
$5.74M -$121K -3,098 -2%
Twin Tree Management
249
Twin Tree Management
Texas
$5.68M +$4.21M +107,855 +163%
RG
250
Rathbones Group
United Kingdom
$5.66M -$29.3M -750,520 -81%

BSX Hedge Fund Activity: Q1 2020 in Review

800 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q1 2020, worth a combined $41.6B — down 28% from $58B a quarter earlier.

Sellers outnumbered buyers: 132 funds closed out of BSX and 89 opened new positions — a net loss of 43 holders — while 306 trimmed existing stakes and 295 added.

The largest buyer was Massachusetts Financial Services, adding an estimated $631M. The largest seller was Capital World Investors, cutting an estimated $1.05B.

  • 800 institutional investors held Boston Scientific (BSX) as of Q1 2020, down from 853 in Q4 2019.
  • Funds reported $41.6B of Boston Scientific stock for Q1 2020, down 28% quarter-over-quarter.
  • 89 funds opened new Boston Scientific positions in Q1 2020 and 132 closed out, a net change of -43 holders.
  • The largest Boston Scientific buyer in Q1 2020 was Massachusetts Financial Services, an estimated $631M added.
  • The largest Boston Scientific seller in Q1 2020 was Capital World Investors, an estimated $1.05B sold.

Based on aggregated 13F filings for Q1 2020.